PAG
AVXL icon

Private Advisor Group’s Anavex Life Sciences AVXL Stock Holding History

Private Advisor Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
504,000
+4,300
+0.9% +$12.7K 0.01% 1224
2026
Q1 		$1.53M Buy
499,700
+79,900
+19% +$346K 0.01% 1174
2025
Q4 		$1.49M Sell
419,800
-35,325
-8% -$216K 0.01% 1172
2025
Q3 		$4.05M Buy
455,125
+55,900
+14% +$567K 0.02% 703
2025
Q2 		$3.68M Buy
399,225
+184,500
+86% +$1.57M 0.02% 692
2025
Q1 		$1.84M Buy
214,725
+184,800
+618% +$1.75M 0.01% 935
2024
Q4 		$321K Sell
29,925
-17,488
-37% -$135K ﹤0.01% 1814
2024
Q3 		$269K Buy
47,413
+4,442
+10% +$25.6K ﹤0.01% 2018
2024
Q2 		$181K Buy
42,971
+46
+0.1% +$186 ﹤0.01% 2172
2024
Q1 		$218K Buy
42,925
+1,945
+5% +$10.9K ﹤0.01% 2061
2023
Q4 		$382K Sell
40,980
-1,850
-4% -$12.7K ﹤0.01% 1636
2023
Q3 		$281K Buy
42,830
+11,150
+35% +$88.7K ﹤0.01% 1663
2023
Q2 		$258K Sell
31,680
-7,500
-19% -$64.3K ﹤0.01% 1718
2023
Q1 		$336K Sell
39,180
-78,700
-67% -$786K ﹤0.01% 1516
2022
Q4 		$1.09K Sell
117,880
-16,800
-12% -$179K ﹤0.01% 1229
2022
Q3 		$1.39M Sell
134,680
-51,800
-28% -$547K 0.02% 766
2022
Q2 		$1.87M Buy
186,480
+63,225
+51% +$599K 0.02% 787
2022
Q1 		$1.52M Buy
+123,255
New +$1.52M 0.01% 915
2020
Q3 		– Sell
-3,000
Closed -$15K – 1712
2020
Q2 		$15K Buy
+3,000
New +$11.3K ﹤0.01% 2710

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Private Advisor Group's AVXL Position: Q2 2026 in Review

Private Advisor Group increased its Anavex Life Sciences (AVXL) stake by 0.86% in Q2 2026, buying an estimated $12.7K and bringing the position to 504,000 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1224.

Private Advisor Group first reported a position in AVXL in Q2 2020 and has held it in 19 quarters since. The position peaked at $4.05M in Q3 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Private Advisor Group held 504,000 shares of Anavex Life Sciences worth $1.31M as of Q2 2026.
  • Private Advisor Group bought 4,300 Anavex Life Sciences shares in Q2 2026, an estimated $12.7K.
  • Anavex Life Sciences made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1224 holding.
  • Private Advisor Group first reported a position in Anavex Life Sciences in Q2 2020 and has held it in 19 quarters since.
  • Private Advisor Group's Anavex Life Sciences position peaked at $4.05M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.